Illinois’s Biometric Information Privacy Act (BIPA) continues to drive a wave of privacy-related litigation across the United States, though a ...

Speaking at a meeting with aid organizations last week, Peter Marocco, the Trump appointee who is now the director of the ...

The cuts at the FDA’s device center could add “months, if not years” to the time it takes to bring products to market, an ...

As discussions intensify about how the second Trump administration will reshape the regulatory landscape for U.S.-based life sciences firms, ...

Since last week, a list titled "prohibited words" has been circulating in official work chats at the U.S. Food and Drug ...

Ionis relies on upfront payments and licensing fees from partners, as well as Spinraza royalties, to drive revenue today, but its rapidly advancing portfolio should help diversify revenue. 2025 is ...

Whether you're settling into your 60s or heading into your 90s, be careful when taking medicines, herbal preparations and ...

One casualty of the mass firings across federal health agencies are regulators who ensure drugs for pets and livestock are ...

The Trump administration is formally designating eight Latin American crime organizations as "foreign terrorist organizations ...

The creation of a “Make America Healthy Again Commission” has raised concern over Washington youths' access to medications ...

Days after Robert F. Kennedy Jr. was sworn in as HHS secretary, health agencies including the FDA, NIH and CDC saw sweeping ...

Policy makers should continue to provide clear rules of the road, increase transparency, apply more effective oversight, and ...